Botanix Pharmaceuticals Limited
BXPHF
$0.25
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.06M | -10.35M | -2.77M | -2.76M | -1.78M |
| Total Depreciation and Amortization | 364.30K | 374.60K | 21.10K | 21.10K | 2.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -257.90K | -265.20K | 887.80K | 886.00K | 553.50K |
| Change in Net Operating Assets | -- | -- | 420.70K | 419.80K | -- |
| Cash from Operations | -9.96M | -10.24M | -1.44M | -1.44M | -1.23M |
| Capital Expenditure | -29.50K | -30.30K | -25.20K | -25.20K | -11.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -248.70K | -255.80K | -1.04M | -1.03M | -4.80M |
| Cash from Investing | -278.20K | -286.10K | -1.06M | -1.06M | -4.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -30.80K | -30.80K | -- | -- | -- |
| Issuance of Common Stock | 231.00K | 231.00K | 36.26M | 36.26M | 14.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -2.09M | -2.09M | -789.20K |
| Cash from Financing | 130.50K | 134.10K | 22.52M | 22.47M | 8.72M |
| Foreign Exchange rate Adjustments | 46.90K | 48.20K | 80.50K | 80.40K | -51.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.06M | -10.34M | 20.10M | 20.06M | 2.63M |
